Loading news...
NEW PORT RICHEY, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions, today reported financial results for the third quarter and nine months ended September 30, 2025.
New Florida stem cell law provides ZEO with new pathways to market and sell regenerative therapy products and advance clinical research initiatives FORT LAUDERDALE, FL / ACCESS Newswire / October 23, 2025 / ZEO ScientifiX™, Inc. (OTCQB:ZEOX) ("ZEO" or the "Company"), a clinical‑stage biopharmaceutical company focused on regenerative therapies including birth tissue biologics, whole blood processing, and exosome nanoparticle science, today announced that it is prepared to capitalize on the potentially rapid expansion of Florida's regenerative medicine market following enactment of the new state stem cell law, SB 1768, effective July 1, 2025. The legislation authorizes licensed physicians to administer non‑FDA‑approved stem cell and other human tissue‑derived therapies for orthopedic, wound care, and pain management indications.
NEW PORT RICHEY, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) ("Zeo," "Zeo Energy," or the "Company"), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions, is confirmed to present at the 2025 Annual Gateway Conference, which is being held September 3-4 at the Four Seasons Hotel in San Francisco, CA.
NEW PORT RICHEY, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and energy efficiency solutions, today reported financial results for the second quarter and six months ended June 30, 2025.
HOUSTON--(BUSINESS WIRE)---- $NASDAQ #CSP--Pickering Energy Partners served as the financial advisor to Heliogen, Inc. in its announced merger with Zeo Energy Corp. (Nasdaq: ZEO).
NEW PORT RICHEY, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today announced that it has completed its previously announced acquisition of Heliogen, Inc. (“Heliogen”), a provider of on-demand clean energy technology solutions (the “Heliogen transaction”).
Stockholders Are Reminded That the Heliogen, Inc. Special Meeting of Stockholders Will Be Held Virtually on Friday, August 8, 2025, at 6:00 a.m. Pacific Time (9:00 a.m.
NEW YORK , July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: ZEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK , July 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: ZEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK , July 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: ZEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK , July 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: ZEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
ZEO Launches New Website and Agency Partnerships to Address Expected Biologics Market Demand Following Florida's New Stem Cell Law FORT LAUDERDALE, FL / ACCESS Newswire / July 9, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company pioneering the development of innovative biological therapeutics, is spearheading an expansion initiative aligned with the implementation of Florida's new SB-1768 stem cell law. With Florida now authorizing the use of non-FDA-approved stem cell therapies that are compliant with the new regulations for the treatment of certain defined conditions, ZEO is seeking to take advantage of the opportunity to set what it believes will be the industry standard through its product platform, new agency partnerships and educational initiatives.
NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW PORT RICHEY, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo”, “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today announced that it has joined the Russell Microcap® Index following the conclusion of the 2025 Russell US Indexes annual reconstitution, effective after the US market open on June 30.
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or the "Company") (NASDAQ: ZEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
LOS ANGELES , June 24, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zeo Energy Corp. ("Zeo" or "the Company") (NASDAQ: ZEO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
FORT LAUDERDALE, FL / ACCESS Newswire / June 24, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company pioneering the research and development of innovative biological therapeutics, has announced their upcoming ZEO Masterclass - a physician-led initiative designed to educate Florida doctors on one of the most significant regulatory changes in recent healthcare history. The New Frontier in Regenerative Medicine With Florida's SB-1768 law ("Law") set to take effect on July 1, 2025, licensed MDs and DOs will, for the first time in accordance with the terms of the Law, be authorized to offer non-FDA-approved stem cell therapies directly to patients in defined medical indications and only if conducted under strict compliance protocols.